Company / Working Capital per Share
DNA X, Inc. Working Capital per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
-$2.61
FY2024
5-year range
-$2.61 / $3.78
FY2020-FY2024
Trend
-1015.9%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share changed -1016% YoY in FY2024, a notable deviation from the 5-year average annual change of -190%.
Based on SEC 10-K filings.
-2.61 in FY2024.
Declined from $0.62 to $-2.61 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- DNA X, Inc.'s working capital per share has declined for 3 consecutive years.
- In FY2024, working capital per share decreased 1015.9% year-over-year.
- Peak working capital per share was recorded in FY2021.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$2.61 | -1015.9% |
| FY2023 | $0.29 | -53.6% |
| FY2022 | $0.62 | -83.7% |
| FY2021 | $3.78 | +208.2% |
| FY2020 | $1.23 | -3.0% |
| FY2019 | $1.27 | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026